HubSpot faces a stark new reality after Q2 results on August 5 triggered an 18.7% single-day collapse, leaving the stock at $210.45 — down 11% on the week — even as every major software peer posted strong gains.
The peer divergence is striking. CRM gained 4.7% on the week. NOW and GWRE each rose more than 12%. WDAY added 12% and ASAN climbed 11.3%. HubSpot moved the opposite direction — down hard — underlining that this was a company-specific event, not a sector rotation. The bull thesis that had powered a 30% pre-earnings rally, documented in the prior note from August 2, was cleanly erased in a single session.
The positioning picture before earnings told a cautious story, and the caution proved warranted. Options traders had been running the put/call ratio above 1.38 every day from July 29 through August 4 — the highest cluster of defensive readings in the past year. The ratio eased back to 1.25 on August 7 as the initial shock absorbed, still modestly above its 20-day mean of 1.22 but no longer flashing the same alarm. Short interest, meanwhile, ticked up 7.2% on August 6 to 10.3% of the float, reversing the modest pre-earnings retreat. The move is small in absolute terms — short interest is roughly where it was a week ago — but the direction has shifted back toward rebuilding. The borrow market remains deeply accommodating: availability at 1,277% means there are far more shares available to lend than are currently borrowed, and the cost to borrow at 0.41% barely registers. Shorts face no mechanical pressure to cover.
The analyst response was swift and overwhelmingly negative, and it changed the Street's structural view of the stock. BMO Capital downgraded to Market Perform from Outperform, cutting its target from $230 to $215. Wolfe Research dropped to Peer Perform from Outperform with no target. Bernstein moved to Market Perform from Outperform, slashing its target from $381 to $220 — the most aggressive reset in the group. Stifel downgraded to Hold from Buy and cut to $200. Among the remaining bulls, Canaccord and RBC held their Buy and Outperform ratings but both trimmed targets materially, to $300 from $335 and $350 respectively. The consensus mean target now sits at $243, implying about 15% upside from current levels — but that number will compress further as slower-moving firms update their models. The bear case, centred on weak net-new ARR growth, AI strategy execution risk, and competitive pressure from Microsoft and ServiceNow, is no longer a minority view.
Factor scores point to limited near-term tailwinds. EPS surprise ranks in just the 29th percentile — consistent with a quarter that disappointed — and the 12-month forward EPS growth score sits at the 25th percentile. The analyst recommendation differential score, at 2 out of 100, reflects how far the Street has tilted negative in the last 48 hours. The ORTEX short score edged up to 49 on August 6 from 47 earlier in the week, a modest move that doesn't yet signal an extreme positioning in either direction.
The insider register adds limited comfort. Executive Chairman Brian Halligan sold 8,500 shares on July 21 at $221, generating $1.9 million — a sale made above current levels and before the earnings shock. CEO Yamini Rangan and CFO Kathryn Bueker both sold smaller amounts on July 1. Net insider activity over 90 days shows $10.2 million in net selling. None of these trades were timed to exploit the post-earnings dip, but the consistent one-way flow from leadership removes one potential contrarian signal.
With the next earnings event scheduled for September 17, the next six weeks will test whether HubSpot can rebuild any analytical credibility on ARR growth trends and the pace of AI product monetisation — the two metrics the downgrading analysts cited most explicitly.
See the live data behind this article on ORTEX.
Open HUBS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.